Pope Woodhead

Pope Woodhead provides strategic consulting and integrated solutions to pharmaceutical companies.

[Pope Woodhead @popewoodhead]

Only a few more days left! Make sure you follow us to our new home, @Huron, before we move on 7/6.

[Pope Woodhead @popewoodhead]

We're moving on 7/6. Follow us at @Huron as we continue to deliver quality insights into the #pharma, #biotech and #medtech industries.

[Pope Woodhead @popewoodhead]

We're helping our clients understand and navigate the #pharma, #biotech and #medtech industries from our new home at @Huron. Follow us there to stay up-to-date.

[Pope Woodhead @popewoodhead]

Hey, followers! @popewoodhead is moving on 7/6. Be sure to follow us at our new home, @Huron.

[Pope Woodhead @popewoodhead]

In this new podcast, our Head of Organisational Development, speaks to Jenny Hughes, Head of Payer Sales and #MarketingExcellence @GSK shares her thoughts and experiences on how to make this kind of flexible organisation work as effectively as possible: https://t.co/tyiDCDqJXm

[Pope Woodhead @popewoodhead]

Our new paper featured in @TOPRANEWS #Regulatory Rapporteur, explores the potential of such #hybrid approaches to fill the knowledge gap between #clinicaltrials and practice. Read the paper here: https://t.co/dMBuj4rzOu #LifeSciences

[Pope Woodhead @popewoodhead]

We are getting excited for #DIA2018 in Boston on 25 - 27th June. Come visit us on Booth 2227 or book a meeting with our experts now: https://t.co/Xh0Qh3Gpq0 #drugsafety #regulatory #healthcare #patientsafety #lifesciences

[Pope Woodhead @popewoodhead]

Missed our latest webinar on "#Regulatory pathways: Expedited Programmes and #ExpandedAccess outside the US and EU".. Click here for the recording: https://t.co/Ua8ks0CfKV #LifeSciences #Healthcare #PatientAccess

[Pope Woodhead @popewoodhead]

Whilst providing #earlyaccess to #treatments for #patients suffering from #rarediseases has long been a #regulatory challenge, advances have been made in recent years, not least outside of the US and EU. Click here to read our new paper: https://t.co/iueZaPlu3d #LifeSciences

[Pope Woodhead @popewoodhead]

Kenneth Beers, Managing Director from the @Huron Life Sciences practice, comments in @eyeforpharma's "The Naked Truth About Outcomes-Based Pricing". Click here to read more: https://t.co/lDFmdm8dvR

[Pope Woodhead @popewoodhead]

Last day at #ISPORBaltimore – don’t forget to stop by booth #113 to catch up with our commercial and digital team.. #ISPOR2018

[Pope Woodhead @popewoodhead]

Missed @popewoodhead drinks reception with "Chips and Dips" @ISPORorg #ISPORBaltimore do not worry, we are holding another reception today from 5pm so be sure to stop by booth #113 #ispor2018

[Pope Woodhead @popewoodhead]

Last Chance! Register now to our upcoming free #webinar based on "Regulatory pathways: Expedited Programmes and Expanded #Access outside the US and EU" presented by our #regulatory expert Richard Huckle - https://t.co/j46BGRhvvV #lifesciences #healthcare #patientaccess

[Giles Thurston @gilesthurston]

Are you using @veevasystems to manage your content and commercial or payer engagements? Be sure to pop along to booth 113 at #ISPORBaltimore to find out how the latest addition to the @popewoodhead family can help simplify this process and reduce your costs #idetailaid

[Pope Woodhead @popewoodhead]

Want to develop your business #strategy to drive more #value out of your product portfolio as #healthcare systems shift to #valuebased care? Meet our global #MedTech and #Biopharma experts at ISPOR US, booth #113. Email [email protected] for a meeting #ISPOR2018

[Pope Woodhead @popewoodhead]

Come and see our experts at booth number 113 at #ISPOR2018 US event in Baltimore on the 21-23rd May and learn about our continuum of offerings that supports the #commercialisation of #pharmaceutical products #MarketAccess #Pharma #LifeSciences #Healthcare #valuebasedcare

[Pope Woodhead @popewoodhead]

Last chance to sign up to our free webinar on "#Regulatorypathways: Expedited Programmes and #ExpandedAccess outside the US and EU". Click here to register: https://t.co/j46BGRhvvV #lifesciences #regulations #patientaccess

[Pope Woodhead @popewoodhead]

New study provides fresh perspective on the effectiveness of additional risk minimisation measures for Bipolar I Disorder. Click here to read our research paper: https://t.co/jn7NCh3k5P #riskminimsation #drugsafety #regulatory #patientsafety #lifesciences #healthcare

[Giles Thurston @gilesthurston]

Who do you trust? For doctors, it's Bristol Myers-Squibb and Biogen https://t.co/N9GO3LdIqF

[Pope Woodhead @popewoodhead]

Ensure continued receipt of our thought pieces, newsletters and events by simply clicking the link here: https://t.co/psWQzTsxrn #GDPR #LifeSciences